Coronary stenting with bioadaptors
- PMID: 39481424
- DOI: 10.1016/S0140-6736(24)02359-6
Coronary stenting with bioadaptors
Conflict of interest statement
I declare advisory board membership with Abbott Vascular, Amgen, Bristol-Myers Squibb, and Vectura; data monitoring committee roles with Amgen; and receipt of speakers' honoraria from Chiesi, Daiichi Sankyo, Novo Nordisk, Menarini, Sanofi, and Terumo.
Comment on
-
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.Lancet. 2024 Nov 2;404(10464):1750-1759. doi: 10.1016/S0140-6736(24)02227-X. Epub 2024 Oct 28. Lancet. 2024. PMID: 39481425 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources